Navigation Links
Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
Date:11/30/2007

Novartis Leads the Drug List With its Alzheimer's Disease Treatment Exelon

TDS

PHILADELPHIA, Nov. 30 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, has issued its quarterly The Ones-to-Watch report. It provides expert insight into the five most promising drugs entering each new phase of clinical development between July and September 2007.

"Bookending this quarter's list are three potential treatments for Alzheimer's disease, two of which are just entering clinical trials and one that has already received FDA approval," said Peter Robins, editorial and content manager, Thomson Scientific. "This quarter's The Ones to Watch report showcases the ongoing drive to find therapies for diseases that impact on ageing and sedentary populations."

Which are the Ones-to-Watch this Quarter?

Topping this quarter's approval list is Exelon TDS, a new transdermal patch formulation of rivastigmine, which looks like a winner for Novartis. In the seven years since its launch, the oral formulation of rivastigmine has seen year-on-year US dollar growth as a treatment of Alzheimer's disease - and Parkinson's disease- associated dementia. The FDA approved Exelon TDS for mild to moderate dementia in July 2007. The EU approval followed two months later. The U.S. launch is expected imminently.

Second on the list is AZOR, which was developed by Daiichi Sankyo for the treatment of hypertension and includes a combination of two component drugs. In previous Phase III trials, all doses of the combination produced greater mean reductio
'/>"/>

SOURCE Thomson Scientific
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Healthcare Study Finds That Hospitals Delivering High-Quality Heart Care Are Efficient and Cost Effective, Too
10. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
11. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Neil Haley, the Total Tutor host of the Simply ... about the importance of capacity to grow a business. , ... and is now a 5 Star Ambassador, Vi Millionaire, and ... titled "The Playful and Powerful Warrior Within You!" and holds ... out for over 1000 days straight. He is also ...
(Date:8/27/2014)... 27, 2014 Overcoming a turbulent past which ... his niche. The Women’s Radio Network, WRNW1, has recently signed ... support and dedication to the WRNW1 family. KC states, “it ... such a positive atmosphere.” After KC Armstrong publicly announced his ... the Howard Stern show, “Howard 100 News,” have decided to ...
(Date:8/27/2014)... A recently published study ... time in correcting coagulopathy to prevent permanent injury or ... anticoagulants and examines medical conditions alleged to be caused ... anticoagulants have been approved by the FDA to reduce ... also known to affect the consistency of the anticoagulation ...
(Date:8/27/2014)... August 27, 2014 The use of ... of life and may eliminate the need for blood ... a recent AllMed webinar, Dr. Zanhua Yi, board certified ... to determining medical necessity of erythropoiesis-stimulating agents (ESAs) in ... , The U.S. Food and Drug Administration (FDA) has ...
(Date:8/27/2014)... Frederick, MD (PRWEB) August 27, 2014 ... and family-friendly practices as the “Most Creative Workplace” ... Frederick County Best Places to Work Awards. , ... the annual event is a joint partnership between ... Department of Economic Development, Frederick County Business Development ...
Breaking Medicine News(10 mins):Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:iHire Named Most Creative Workplace in Frederick, MD 2
... tall extremes may put added pressure on joints, study ... Common genetic variants associated with osteoarthritis may also play ... a U.S.-European study. , The findings, which included an ... are exciting for a number of reasons, said ...
... Childrens Hospital has been named the national lead ... the German-manufactured pediatric heart pump called Berlin Heart ... Fraser, Jr., MD, chief of pediatric and congenital ... E. DeBakey Department of Surgery at Baylor College ...
... transplanted because of the generosity of,donors and their families, ... Perkiomenville, 2007 was a year that brought the greatest ... for a multi-organ,transplant, her parents Shane and Jill watched ... a miracle., That wish was answered just three ...
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... Joined by New York City Mayor,Michael Bloomberg, Lance ... today discussed Lance,s request to the Surgeons General,Collective ... "This year alone, 1.4 million Americans are ... likely lose their lives to the disease," said,Lance ...
... the San Diego Supercomputer Center and other parts of ... in Parkinsons Disease, fusion energy and climate change - ... Energy (DOE) as part of its 2008 Innovative and ... , In total, the DOEs Office of Science awarded ...
Cached Medicine News:Health News:Genes Linked to Height Also Tied to Osteoarthritis Risk 2Health News:National study will look at German-made heart pump for children needing heart transplants 2Health News:National study will look at German-made heart pump for children needing heart transplants 3Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 2Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 3Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3
(Date:8/26/2014)... Aug. 26, 2014  When it comes to diabetes supplies, ... relevance. But Timesulin happens to answer a real medical ... pen on the market, Timesulin shows how long it,s ... preventing from missed or double insulin doses. Very easy ... back on the insulin pen after an injection. There ...
(Date:8/26/2014)... 2014  Ethicon* is introducing three new endocutter and ... of bariatric procedures such as sleeve gastrectomy and gastric ... the 19th World Congress of International Federation for the ... Ethicon is featuring the new ECHELON FLEX ™ ... G2 Articulating Tissue Sealer alongside the HARMONIC ACE ® ...
(Date:8/26/2014)... , Aug. 26, 2014  Avanir Pharmaceuticals, Inc. ... enrollment of the first patient into a phase ... tolerability of AVP-786 for the adjunctive treatment of ... investigational drug consisting of a combination of deuterium ... "There are millions of people with MDD who ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 2Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 3Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 4Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 5Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 6Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6
... Nov. 10, 2011 Shands Jacksonville Medical ... Masimo (NASDAQ: MASI ) ... Center to Masimo rainbow® SET Pulse CO-Oximetry™ technology for ... acute care hospital, which also operates one of the ...
... 2011 Cancer Support Community in collaboration with Center ... to host a workshop from the popular Frankly ... workshop will address the topic of breast reconstruction options, ... MD, and a panel of breast cancer survivors. The ...
Cached Medicine Technology:Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 2Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 3Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 4Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 5Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 6Cancer Support Community in Collaboration with the Center for Breast Health at Washington Hospital Center Hosts Free Frankly Speaking About Cancer: Spotlight on Breast Reconstruction Workshop on Thursday, November 10 2Cancer Support Community in Collaboration with the Center for Breast Health at Washington Hospital Center Hosts Free Frankly Speaking About Cancer: Spotlight on Breast Reconstruction Workshop on Thursday, November 10 3
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full menu ... thyroid, reproductive, cardiac, and anemia assays. ,The ... bar-coded primary tube sampling, auto dilution, auto ...
... Tosoh, innovators of automated random access immunoassay testing, ... builds on the proven reliability of Tosohs original ... rapid result processing, and continuous process operation., Test ... T4 FT3 FT4 T-Uptake ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... Vitros ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The Vitros ECi can simultaneously process ...
Medicine Products: